r google-plus facebook twitter linkedin2 nujij P P M G W Monitor Nieuwsbrief pdclogo man met tas twitter boek

Laatste nieuws: 

Annual Medicines for Europeand IGBA Conference, Warschau

Koninklijk Paleis in Warschau
datum 12 juni 2019 - 14 juni 2019
plaats Warschau, Polen
locatie Sofitel Warsaw Victoria Toon locatie
organisatie Medicines for Europe

2019 PROGRAMME

REGISTER NOW

Last minute registrations: please make sure the payment is received before the event! Many thanks

HOTEL ACCOMMODATION

Hotel reservations are subject to availability so book ASAP!

Sofitel Warsaw Victoria - Reservation Department

P: + 48 22 657 82 85 - E: h3378-re@sofitel.com

ADVERTISING, EXHIBITION & SPONSORSHIP OPPORTUNITIES

Committing to Global Health:

Inhoud

1.

Balancing Access and Sustainability

The Joint 25th Medicines for Europe and 22nd IGBA Annual Conference will bring together over 300 experts including medicine manufacturers, stakeholders and governments to evaluate market trends, innovative commercial strategies, challenges for the pharma sector and new opportunities to improve access to medicines for patients. At this unique event, participants will not only gain new insight but also discuss the commitment of the off-patent industry towards Global Health.

Join us in this unique opportunity to network in the beautiful capital of Poland, Warsaw.

Why should you attend?

  • Get updates on the latest developments and market trends in the off-patent pharmaceutical industry;
  • Meet high-level international speakers to understand the global relevance of Generic, Biosimilar and Value Added Medicines;
  • Network with policy-makers, regulators, payers and peers;
  • Discover business opportunities in pharmaceutical markets around the world.

view the programme

jQuery(document).ready(function($){ $("#team-7970 .team-items").owlCarousel({ items : 5, //10 items above 1000px browser width autoHeight:true, responsiveClass:true, responsive:{ 0:{ items:1, nav:true }, 600:{ items:2, nav:true }, 900:{ items:2, nav:true }, 1000:{ items:5, nav:true, } }, navText : ["",""], nav: true, }); });

Marc-Alexander Mahl

President Medicines for Europe and Executive Vice President, Business Unit Generics and Complex Formulations ELAMA & Asia-Pacific Pharmaceuticals and Devices Division, Fresenius Kabi Deutschland

Marc-Alexander MahlPresident Medicines for Europe and Executive Vice President, Business Unit Generics and Complex Formulations ELAMA & Asia-Pacific Pharmaceuticals and Devices Division, Fresenius Kabi Deutschland

Marcie McClintic Coates

Head of Global Policy, Mylan

Marcie McClintic CoatesHead of Global Policy, Mylan

Randall Stanicky

Managing Director, RBC Capital Markets

Randall StanickyManaging Director, RBC Capital Markets

Per Troein

Vice President Strategic Partners, IQVIA

Per TroeinVice President Strategic Partners, IQVIA

Nick Haggar

Chief Executive Officer, Zentiva

Nick HaggarChief Executive Officer, Zentiva

Karan Ambwani

Head of Commercial Strategy & Alliances, Teva

Karan AmbwaniHead of Commercial Strategy & Alliances, Teva

Mariângela Simão

Assistant Director General for Drug Access, Vaccines and Pharmaceuticals, WHO

Mariângela SimãoAssistant Director General for Drug Access, Vaccines and Pharmaceuticals, WHO

Jim Keon

President - Canadian Generic Pharmaceutical Association (CGPA) and President - Biosimilars Canada

Jim KeonPresident - Canadian Generic Pharmaceutical Association (CGPA) and President - Biosimilars Canada

Tobias Dolle

Associate, FratiniVergano - European Lawyers

Tobias DolleAssociate, FratiniVergano - European Lawyers

Claire Hempshall

Senior Principal, IQVIA

Claire HempshallSenior Principal, IQVIA

David Jauch

Director Government Relations - Fresenius Kabi

David JauchDirector Government Relations - Fresenius Kabi

Warwick Smith

Director General, British Generic Manufacturers Association (BGMA) and British Biosimilars Association (BBA)

Warwick SmithDirector General, British Generic Manufacturers Association (BGMA) and British Biosimilars Association (BBA)

Jonathan Kimball

Vice President of Trade and International Affairs, Association for Accessible Medicines (AAM)

Jonathan KimballVice President of Trade and International Affairs, Association for Accessible Medicines (AAM)

Suzette Kox

Secretary General, International Generic and Biosimilar medicines Association (IGBA)

Suzette KoxSecretary General, International Generic and Biosimilar medicines Association (IGBA)

Dr. Rob Lionberger

Director, Office of Research and Standards, Office of Generic Drugs, FDA

Dr. Rob LionbergerDirector, Office of Research and Standards, Office of Generic Drugs, FDA

Nicholas Cappuccino

Chair of the IGBA Science Committee and IGBA Member of the ICH Management Committee

Nicholas CappuccinoChair of the IGBA Science Committee and IGBA Member of the ICH Management Committee

Deus Mubangizi

Coordinator Prequalification Team (PQT) Regulation of Medicines and other Health Technologies (RHT), World Health Organization (WHO)

Deus MubangiziCoordinator Prequalification Team (PQT) Regulation of Medicines and other Health Technologies (RHT), World Health Organization (WHO)

Frances (Fran) M. Zipp

President & CEO, Lachman Consultant Services Inc.

Frances (Fran) M. ZippPresident & CEO, Lachman Consultant Services Inc.

Matthew Scherer

International Policy Advisor, Europe Office, U.S. Mission to the European Union, U.S. Food and Drug Administration

Matthew SchererInternational Policy Advisor, Europe Office, U.S. Mission to the European Union, U.S. Food and Drug Administration

Aidan Fry

Editor, Generics Bulletin - Informa

Aidan FryEditor, Generics Bulletin - Informa

David R. Gaugh, R.Ph

Senior Vice President for Sciences and Regulatory Affairs, Association for Accessible Medicines (AAM)

David R. Gaugh, R.PhSenior Vice President for Sciences and Regulatory Affairs, Association for Accessible Medicines (AAM)

Sudarshan Jain

Secretary General, Indian Pharmaceutical Alliance

Sudarshan JainSecretary General, Indian Pharmaceutical Alliance

Adrian van den Hoven

Director General, Medicines for Europe

Adrian van den HovenDirector General, Medicines for Europe

Michele Uda

Director General, Assogenerici and Chair of the Generic Market Access Committee, Medicines for Europe

Michele UdaDirector General, Assogenerici and Chair of the Generic Market Access Committee, Medicines for Europe

Adele Paterson

Chief Executive Officer and Head of Corporate Partnerships, International Health Partners

Adele PatersonChief Executive Officer and Head of Corporate Partnerships, International Health Partners

James Burt

Executive Vice President Europe & MENA, Accord Healthcare Ltd

James BurtExecutive Vice President Europe & MENA, Accord Healthcare Ltd

Deborah M. Autor

Head of Strategic Global Quality & Regulatory Policy, Mylan

Deborah M. AutorHead of Strategic Global Quality & Regulatory Policy, Mylan

Jerzy Starak

President of the Supervisory Board, Polpharma

Jerzy StarakPresident of the Supervisory Board, Polpharma

Markus W. Sieger

CEO and President of the Management Board, Polpharma Group

Markus W. SiegerCEO and President of the Management Board, Polpharma Group

Krzysztof Kopeć

President of the Board, Polish Union of Employers in Pharmaceutical Industry (PZPPF)

Krzysztof KopećPresident of the Board, Polish Union of Employers in Pharmaceutical Industry (PZPPF)

Maciej Miłkowski

Deputy Minister of Health, Poland

Maciej MiłkowskiDeputy Minister of Health, Poland

Stefan Hendriks

Global Head Biopharmaceuticals, Sandoz

Stefan HendriksGlobal Head Biopharmaceuticals, Sandoz

Gustaf Befrits

Coordinator Introduction of Biosimilars, Stockholm County Council, Sweden

Gustaf BefritsCoordinator Introduction of Biosimilars, Stockholm County Council, Sweden

Marnie Peterson

Chief Executive Officer, Generic and Biosimilar Medicines Association, Australia

Marnie PetersonChief Executive Officer, Generic and Biosimilar Medicines Association, Australia

Zorana Maravic

Director of Operations, Digestive Cancers Europe

Zorana MaravicDirector of Operations, Digestive Cancers Europe

Professor Rob Duncombe

Director of Pharmacy, The Christie NHS Foundation Trust and Director, The Christie Pharmacy Company, UK

Professor Rob DuncombeDirector of Pharmacy, The Christie NHS Foundation Trust and Director, The Christie Pharmacy Company, UK

Dr Paul Cornes

Oncologist, Comparative Outcomes Group, UK

Dr Paul CornesOncologist, Comparative Outcomes Group, UK

Arun Narayan

Head of Global Portfolio Strategy & European Business Operations, Mylan and Chairman of the Value Added Medicines Sector Group

Arun NarayanHead of Global Portfolio Strategy & European Business Operations, Mylan and Chairman of the Value Added Medicines Sector Group

Francis Arickx

Head Directorate Reimbursement of Medicines and Pharmaceutical Policy, RIZIV-INAMI, Belgium

Francis ArickxHead Directorate Reimbursement of Medicines and Pharmaceutical Policy, RIZIV-INAMI, Belgium

Sofia Romagosa Vilarnau

Junior Projects and Engagement Officer, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)

Sofia Romagosa VilarnauJunior Projects and Engagement Officer, European Federation of Allergy and Airways Diseases Patients' Associations (EFA)

Aurelio Arias

Senior Consultant, European Thought Leadership - IQVIA

Aurelio AriasSenior Consultant, European Thought Leadership - IQVIA

Kenneth V. Phelps

President and Founder, Camargo Pharmaceutical Services

Kenneth V. PhelpsPresident and Founder, Camargo Pharmaceutical Services

Carsten Brockmeyer

Chief Executive Officer, Formycon

Carsten BrockmeyerChief Executive Officer, Formycon

Francesco Balestrieri

Region Head Europe and Incoming ad interim CEO, Sandoz

Francesco BalestrieriRegion Head Europe and Incoming ad interim CEO, Sandoz

TBN

TBN

3.

PLATINUM SPONSOR

4.

GOLD SPONSORS

5.

SILVER SPONSOR

6.

BRONZE SPONSOR

7.

CONFERENCE SPONSORS

Medicines for Europe is honored to be collaborating with the following partners to make this year’s conference

8.

CONTACT

Lucia Romagnoli

M: +44 (0) 7 562 87 68 73

For more information on advertising, exhibition and sponsorship packages:

Trudy Beks

M: +31 6 4119 0824

Media Requirements and Press Policy

For any other media enquiries:

Kate O’Regan

P: +32 (0)2 239 20 19


9.

Meer over...

Terug naar boven